Peripheral neuropathy decisions — 2025

The appeal for service connection for multiple conditions was dismissed due to the untimely filing of the Board Appeal request.

The Board denied the Veteran's claims for increased ratings for diabetic peripheral neuropathy in both upper and lower extremities, finding that the symptoms did not warrant a higher rating.

The Board granted service connection for various conditions, including neck disability manifested by pain and diabetes mellitus type II, secondary to the Veteran's service-connected bilateral knee degenerative arthritis. The other conditions were also granted as they are caused by the now-service-connected diabetes mellitus type II.

The Board granted a rating of 40 percent disabling for neuropathy, peripheral conditions affecting the right and left lower extremities (sciatic nerve), with an effective date of February 20, 2023.

The Board granted an effective date of March 2, 2023 for heart disease and September 28, 2023 for chronic renal failure, while denying earlier effective dates for PTSD, migraines, diabetes mellitus type II, hypertension, and bilateral hearing loss. The Board also granted a 70 percent evaluation for PTSD.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board granted service connection for tinnitus and denied service connection for hypertension, heart disease, kidney condition, diabetes, left lower extremity neuropathy, left upper extremity neuropathy, right lower extremity neuropathy, right upper extremity neuropathy, depression, and bilateral hearing loss.

The Board remands the Veteran's claims for service connection for peripheral neuropathy and restless leg syndrome of both lower extremities to provide notice concerning his right to a pre-decisional hearing before the AOJ.

The Board remands the claims for further development as there has not been substantial compliance with previous remand instructions.

The Board remands the claims for service connection for diabetes mellitus type II and bilateral lower extremity (BLE) neuropathy to obtain additional private treatment records.

The Board remands the claims for service connection for diabetes mellitus, type II (DMII), hypertension, peripheral vascular disease, bilateral diabetic retinopathy, and bilateral upper and lower diabetic peripheral neuropathy due to insufficient evidence regarding toxic exposures during military service.

The Board remands the claims for additional development, including obtaining VA medical opinion and correcting duty to assist errors.

The Board remands the claims for service connection for various disabilities, including a neck disability, shoulder disabilities, hand disabilities, lower back disability, knee disabilities, psychiatric disorder, sinus headache, carpal tunnel syndrome, peripheral neuropathy, hypertension, and tinnitus, to ensure that VA has satisfied its duty to assist with regard to verifying all periods of service and obtaining medical records associated with the Veteran's service.

The Board granted an effective date of May 24, 2021, for service connection for right and left upper extremity neuropathy and a 30 percent rating for the right upper extremity, while denying a higher rating for the left upper extremity.

The Board granted service connection for bilateral hearing loss and dismissed the appeal for an earlier effective date for tinnitus prior to February 2, 2024. The claims for a rating greater than 10 percent for tinea pedis, and for service connection for lumbar spine and bilateral lower extremity nerve conditions were remanded.

The Board granted entitlement to special monthly compensation (SMC) at the (l) level based on loss of use of bilateral lower extremities due to service-connected bilateral lower extremity peripheral neuropathy.

The Board granted an effective date of August 9, 2023 for the award of service connection and increased ratings for several conditions, but remanded claims for higher initial disability ratings.

The Board of Veterans' Appeals remands the claims for further action as required by a Joint Motion for Remand.

The Board granted a rating of 20 percent for both the left and right lower extremity neuropathy, as they are each productive of moderate incomplete paralysis of the sciatic nerve.

The Board granted increased disability ratings of 70 percent for right upper extremity peripheral neuropathy, 60 percent for left upper extremity peripheral neuropathy, and 40 percent each for right and left lower extremity peripheral neuropathy, all effective from January 12, 2019.